On the HIV vaccine front:

Science Daily is reporting that research is promising in the early development of anti-HIV neutralizing antibodies- which means good news on the HIV vaccine front. Excerpt:

…a major stumbling block in the development of an effective vaccine against HIV is the inability to elicit, by immunization, broadly reactive neutralizing antibodies (NAbs). These antibodies bind to the surface of HIV and prevent it from attaching itself to a cell and infecting it. However, a fraction of people infected with HIV develop broadly neutralizing antibodies (bNAbs) capable of preventing cell-infection by diverse HIV isolates, which are the type of antibodies researchers wish to elicit by vaccination.

The full article here.